Logo image of TRZ.CA

TRANSAT A.T. INC (TRZ.CA) Stock Fundamental Analysis

TSX:TRZ - Toronto Stock Exchange - CA89351T4019 - Common Stock - Currency: CAD

1.75  -0.02 (-1.13%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to TRZ. TRZ was compared to 8 industry peers in the Passenger Airlines industry. TRZ may be in some trouble as it scores bad on both profitability and health. TRZ is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

TRZ had negative earnings in the past year.
TRZ had a positive operating cash flow in the past year.
In the past 5 years TRZ always reported negative net income.
In multiple years TRZ reported negative operating cash flow during the last 5 years.
TRZ.CA Yearly Net Income VS EBIT VS OCF VS FCFTRZ.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

With a Return On Assets value of -4.15%, TRZ is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -4.15%
ROE N/A
ROIC N/A
ROA(3y)-8.25%
ROA(5y)-13.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TRZ.CA Yearly ROA, ROE, ROICTRZ.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

The Gross Margin of TRZ (48.77%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of TRZ has remained more or less at the same level.
TRZ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y41.13%
GM growth 5Y0.74%
TRZ.CA Yearly Profit, Operating, Gross MarginsTRZ.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

0

2. Health

2.1 Basic Checks

TRZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
TRZ has more shares outstanding than it did 1 year ago.
The number of shares outstanding for TRZ has been increased compared to 5 years ago.
The debt/assets ratio for TRZ is higher compared to a year ago.
TRZ.CA Yearly Shares OutstandingTRZ.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
TRZ.CA Yearly Total Debt VS Total AssetsTRZ.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 0.51, we must say that TRZ is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.51, TRZ is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.51
ROIC/WACCN/A
WACC3.66%
TRZ.CA Yearly LT Debt VS Equity VS FCFTRZ.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

TRZ has a Current Ratio of 0.81. This is a bad value and indicates that TRZ is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of TRZ (0.81) is worse than 70.00% of its industry peers.
TRZ has a Quick Ratio of 0.81. This is a bad value and indicates that TRZ is not financially healthy enough and could expect problems in meeting its short term obligations.
TRZ has a worse Quick ratio (0.78) than 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.78
TRZ.CA Yearly Current Assets VS Current LiabilitesTRZ.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

The earnings per share for TRZ have decreased strongly by -1012.50% in the last year.
TRZ shows a small growth in Revenue. In the last year, the Revenue has grown by 7.72%.
TRZ shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.26% yearly.
EPS 1Y (TTM)-1012.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.41%
Revenue 1Y (TTM)7.72%
Revenue growth 3Y197.42%
Revenue growth 5Y2.26%
Sales Q2Q%3.19%

3.2 Future

The Earnings Per Share is expected to grow by 21.00% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 4.56% on average over the next years.
EPS Next Y14.55%
EPS Next 2Y23.31%
EPS Next 3Y21%
EPS Next 5YN/A
Revenue Next Year4.75%
Revenue Next 2Y4.47%
Revenue Next 3Y4.56%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
TRZ.CA Yearly Revenue VS EstimatesTRZ.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
TRZ.CA Yearly EPS VS EstimatesTRZ.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

1

4. Valuation

4.1 Price/Earnings Ratio

TRZ reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year TRZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TRZ.CA Price Earnings VS Forward Price EarningsTRZ.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of TRZ indicates a somewhat cheap valuation: TRZ is cheaper than 70.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.36
TRZ.CA Per share dataTRZ.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

A more expensive valuation may be justified as TRZ's earnings are expected to grow with 21.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y23.31%
EPS Next 3Y21%

0

5. Dividend

5.1 Amount

No dividends for TRZ!.
Industry RankSector Rank
Dividend Yield N/A

TRANSAT A.T. INC

TSX:TRZ (2/21/2025, 7:00:00 PM)

1.75

-0.02 (-1.13%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)12-10 2024-12-10/amc
Earnings (Next)03-13 2025-03-13/amc
Inst Owners26.66%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap69.25M
Analysts45.45
Price Target1.8 (2.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)98.64%
Min EPS beat(2)-93.62%
Max EPS beat(2)290.9%
EPS beat(4)1
Avg EPS beat(4)25.25%
Min EPS beat(4)-93.62%
Max EPS beat(4)290.9%
EPS beat(8)5
Avg EPS beat(8)222%
EPS beat(12)6
Avg EPS beat(12)146.99%
EPS beat(16)8
Avg EPS beat(16)108.58%
Revenue beat(2)1
Avg Revenue beat(2)0.08%
Min Revenue beat(2)-2.87%
Max Revenue beat(2)3.03%
Revenue beat(4)2
Avg Revenue beat(4)0.02%
Min Revenue beat(4)-2.87%
Max Revenue beat(4)3.03%
Revenue beat(8)4
Avg Revenue beat(8)-0.06%
Revenue beat(12)5
Avg Revenue beat(12)-2.13%
Revenue beat(16)7
Avg Revenue beat(16)-0.19%
PT rev (1m)-5.38%
PT rev (3m)0.57%
EPS NQ rev (1m)-11.1%
EPS NQ rev (3m)-40.37%
EPS NY rev (1m)-14.79%
EPS NY rev (3m)-14.79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)2.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.02
P/FCF N/A
P/OCF 0.73
P/B N/A
P/tB N/A
EV/EBITDA 9.36
EPS(TTM)-3.56
EYN/A
EPS(NY)-3.04
Fwd EYN/A
FCF(TTM)-1.11
FCFYN/A
OCF(TTM)2.39
OCFY136.72%
SpS82.99
BVpS-22.47
TBVpS-22.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.15%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.77%
FCFM N/A
ROA(3y)-8.25%
ROA(5y)-13.98%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y41.13%
GM growth 5Y0.74%
F-Score3
Asset Turnover1.19
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 9.43
Cap/Depr 62.46%
Cap/Sales 4.22%
Interest Coverage N/A
Cash Conversion 45.28%
Profit Quality N/A
Current Ratio 0.81
Quick Ratio 0.78
Altman-Z 0.51
F-Score3
WACC3.66%
ROIC/WACCN/A
Cap/Depr(3y)38.18%
Cap/Depr(5y)29.63%
Cap/Sales(3y)2.7%
Cap/Sales(5y)3.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1012.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%63.41%
EPS Next Y14.55%
EPS Next 2Y23.31%
EPS Next 3Y21%
EPS Next 5YN/A
Revenue 1Y (TTM)7.72%
Revenue growth 3Y197.42%
Revenue growth 5Y2.26%
Sales Q2Q%3.19%
Revenue Next Year4.75%
Revenue Next 2Y4.47%
Revenue Next 3Y4.56%
Revenue Next 5YN/A
EBIT growth 1Y-114.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year452.18%
EBIT Next 3Y100.43%
EBIT Next 5YN/A
FCF growth 1Y-116.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-70.58%
OCF growth 3YN/A
OCF growth 5Y-15.21%